Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Modern Rheumatology|May 16, 2020
Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosisKosuke Ebina, Jun Hashimoto, Masafumi Kashii, et al.
Scientific Reports|October 27, 2022
A novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritisShohei Oyama, Kosuke Ebina, Yuki Etani, et al.
Foot & Ankle Orthopaedics|January 31, 2022
Modified Anterolateral Approach for Total Ankle ArthroplastyMakoto Hirao, Kosuke Ebina, Yuki Etani, et al.
Bone|August 11, 2020
Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosisKosuke Ebina, Makoto Hirao, Hideki Tsuboi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 31, 2024
An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case-control studyKosuke Ebina, Yoshio Nagayama, Masafumi Kashii, et al.
JCI Insight|November 22, 2023
Anti-NF-κB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in miceKenji Takami, Kazuki Okamoto, Yuki Etani, et al.
Bone|July 10, 2020
Combined effect of teriparatide and an anti-RANKL monoclonal antibody on bone defect regeneration in mice with glucocorticoid-induced osteoporosisYuki Etani, Kosuke Ebina, Makoto Hirao, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 8, 2026
Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort studyToshitaka Yukishima, Tomonori Kobayakawa, Yuji Hirano, et al.
Science Signaling|November 1, 2022
Semaphorin 4D induces articular cartilage destruction and inflammation in joints by transcriptionally reprogramming chondrocytesTomohiko Murakami, Yoshifumi Takahata, Kenji Hata, et al.
Bone|January 5, 2025
Impact of prior teriparatide treatment on the effectiveness of romosozumab in patients with postmenopausal osteoporosis: A case-control studyKosuke Ebina, Tomonori Kobayakawa, Yuki Etani, et al.
Pageof 8